creening information for parents for early detection of ... · newborn hearing screening hearing...

2
How do we carry out the mucoviscidosis screening? Normally, no additional blood taking is necessary for this examination. The mucoviscidosis screening takes place at the same time and from the same blood sample which was taken from your baby for the extended newborn screening. The laboratory first determines the so called enzyme immunoreactive trypsin (IRT). In case of a heightened factor, a second test for the pancreatitis associated protein (PAP) takes places from the same blood sample. If the second factor is also heightened, a DNA test (genetic examination) takes place with the aim to detect one of the 31 most frequently appearing genetic alterations which appear at presence of mucoviscidosis. If the first test is very heightened or at least one genetic alteration was detected, the mucoviscidosis screening is declared to be suspicious. A combination of the different test steps guarantees a maximum precision and reliability of the test results. However, in very rare cases it is also possible that a child falls ill with mucoviscidosis and did not have a suspicious test result during this early detection examination. What happens at presence of a suspicious screening result? In case of a result which has to be controlled again, you and your baby are referred to a specialised mucoviscidosis centre where a sweat test takes place as confirmation examination. Please consider that a result which needs a follow up examination does not mean that your newborn has mucoviscidosis. Only one out of five children with a suspicious result and who needed a follow up examination actually has mucoviscidosis. Furthermore, the sweat test is harmless and painless and does not stress your baby. You decide for your baby! The participation in the mass screening is voluntary. Also the costs for this examination are taken if you are insured in a statutory health insurance. The results of this examination underlie the medical confidentiality and may not be transmitted to other persons without your agreement. The screening laboratory transmits the results directly to the responsible person who contacts you in case of a positive result. You have the right to revoke your agreement to participate in the mucoviscidosis mass screening at any time. Notice: Also an early treatment cannot prevent consequences of the mentioned diseases completely in all cases. However, an immediate treatment makes a normal development possible for concerned children in the most cases. Important FRAMEwork conditions The participation in the newborn screening examinations is voluntary. Your agreement to participate includes a test for the here mentioned diseases. Data protection: The filter paper card and the part with personal data of you and your baby are separated after the analyses have been finished. The examined dried blood sample is destroyed after finishing of all analyses (at the latest after 3 months). The results of the examinations underlie the medical confidentiality and may not be transmitted to other persons without your agreement. The costs for this examination are overtaken if you are insured in a statutory health insurance. If you are privately insured the costs are normally also overtaken, however, for further details please contact your insurance company. In case you have any further questions about the topic of the newborn screening, please contact your materny clinic or your paediatrist. Our team of the newborn screening laboratory wishes you and your baby all the best for your future. Universitätsklinikum Magdeburg A .ö.R. Otto-von-Guericke-Universität Institut für Klinische Chemie und Pathobiochemie Labor für Neugeborenenscreening Leipziger Straße 44 / Haus 39 39120 Magdeburg - Germany Telephone: +49 391 67-13959 Telefax: +49 391 67-290361 [email protected] www.stwz.ovgu.de www.med.uni-magdeburg.de Flyer Date: 01/2017 Which diseases are included in the newborn screening? Congenital adrenal hyperplasia Endocrine disorder due to defect of the adrenal cortex: androgenisation at girls, possible lethal outcome at salt wasting crisis. Treatment by hormone intake. (Frequency: approx. 1/10,000 newborns) Maple syrup urine disease Degradation defect of amino acids: mentally handicapped, coma, possible lethal outcome. Treatment by special diet. (Frequency: approx. 1/200,000 newborns) Biotinidase deficiency Metabolic defect of the vitamin biotin: Skin alteration, metabolic crisis, mentally handicapped. Treatment by biotin intake. (Frequency: 1/80,000 newborns) Carnitine metabolic disorder Metabolic disorder of fatty acids: metabolic crisis, coma, possible lethal outcome. Treatment by special diet. (Frequency: approx. 1/100,000 newborns) Galactosemia Impaired metabolism of lactose sugars: Blindness, physical and intellectual disability, liver failure, possibly resulting in death. Treatment through a special diet (Frequency: approx. 1/40,000 newborns). Glutaric acidemia type 1 Degradation defect of amino acids: permanent movement disorder, sudden metabolic crisis. Treatment by special diet. (Frequency: approx. 1/80,000 newborns) Hypothyreosis Congenital hypothyrosis: Severe mentally and physical development disorder. Treatment by hormone intake. (Frequency: approx. 1/4,000 newborns) Isovaleric acidaemia: Degradation defect of amino acids: mentally handicapped, coma. Treatment by special diet and intake of amino acids. (Frequency: approx. 1/50,000 newborns) LCHAD/VLCAD Metabolic defect of long-chain fatty acids: metabolic crisis, coma, myasthenia, myocardial insufficiency, possible lethal outcome. Treatment by special diet, prevention of starvation periods. (Frequency: approx. 1/80,000 newborns) MCAD-deficiency Energy production defect from fatty acids: metabolic crisis, coma, possible lethal outcome. Treatment by intake of carnitine, prevention of starvation periods. (Frequency: approx. 1/10,000 newborns) Phenylketonuria Metabolic defect of the amino acid phenylalanin: seizures, spasticity, mentally handicapped. Treatment by special diet. (Frequency: approx. 1/10,000 newborns) Mucoviscidosis (since 09/2016) Also called cystic fibrosis. Defect of a transport protein (CFTR). Causes a salt exchange disorder in the gland cells. Viscous mucous formation in the respiratory tract and organs which become permanently inflamed. Relief and improvement of symptoms by following treatment: inhalation, physiotherapy, special diet, drugs. (Frequency: 1/3,300 newborns) Newborn hearing screening Hearing disorders are the most frequent sensory disorders during infancy with multiple reasons, partly appearing in combination with other diseases (cardiac-, renal- and visual disorders). Early detection and therapy starting are condition for an optimal linguistic and mental development. Too late detection causes permanent damages. Therapy: among others support, hearing device supply and if necessary cochlea implant. (Frequency approx. 1-3/1000 newborns) NEWBORN SCREENING Information for parents For early detection of congenital disorders at newborns. Inclusive - Screening for mucoviscidosis

Upload: others

Post on 14-Oct-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CREENING Information for parents For early detection of ... · Newborn hearing screening Hearing disorders are the most frequent sensory dis orders during infancy with multiple reasons,

Ho

w

do

w

e

carr

y

ou

t th

e

mu

cov

isci

do

sis

scre

en

ing

?

No

rma

lly,

no

a

dd

itio

na

l b

loo

d

takin

g

is

ne

cess

ary

fo

r th

is

exa

min

ati

on

. T

he

m

uco

visc

ido

sis

scre

en

ing

ta

ke

s p

lace

a

t th

e

sam

e t

ime

an

d f

rom

th

e s

am

e b

loo

d s

am

ple

wh

ich

wa

s ta

ke

n

fro

m y

ou

r b

ab

y fo

r th

e e

xte

nd

ed

ne

wb

orn

scr

ee

nin

g.

Th

e

lab

ora

tory

fi

rst

de

term

ine

s th

e

so

call

ed

e

nzy

me

imm

un

ore

act

ive

try

psi

n (

IRT

). I

n c

ase

of

a h

eig

hte

ne

d f

act

or,

a

seco

nd

te

st f

or

the

pa

ncr

ea

titi

s a

sso

cia

ted

pro

tein

(P

AP

) ta

kes

pla

ces

fro

m t

he

sa

me

blo

od

sa

mp

le.

If t

he

se

con

d f

act

or

is a

lso

he

igh

ten

ed

, a

DN

A t

est

(g

en

eti

c e

xam

ina

tio

n)

tak

es

pla

ce w

ith

the

a

im

to

de

tect

o

ne

o

f th

e

31

m

ost

fr

eq

ue

ntl

y

ap

pe

ari

ng

ge

ne

tic

alt

era

tio

ns

wh

ich

ap

pe

ar

at

pre

sen

ce o

f m

uco

vis

cid

osi

s.

If

the

fi

rst

test

is

ve

ry

he

igh

ten

ed

o

r a

t le

ast

o

ne

g

en

eti

c

alt

era

tio

n

wa

s d

ete

cte

d,

the

m

uco

vis

cid

osi

s sc

ree

nin

g

is

de

cla

red

to

be

su

spic

iou

s.

A c

om

bin

ati

on

of

the

dif

fere

nt

test

ste

ps

gu

ara

nte

es

a m

axi

mu

m

pre

cisi

on

an

d r

eli

ab

ilit

y o

f th

e t

est

re

sult

s. H

ow

eve

r, i

n v

ery

ra

re

case

s it

is

als

o p

oss

ible

th

at

a c

hil

d f

all

s il

l w

ith

mu

covis

cid

osi

s

an

d

did

n

ot

ha

ve

a

su

spic

iou

s te

st

resu

lt

du

rin

g

this

e

arl

y

de

tect

ion

exa

min

ati

on

.

Wh

at

ha

pp

en

s a

t p

rese

nce

o

f a

su

spic

iou

s

scre

en

ing

re

sult

?

In c

ase

of

a r

esu

lt w

hic

h h

as

to b

e c

on

tro

lle

d a

ga

in,

yo

u a

nd

yo

ur

ba

by

are

re

ferr

ed

to

a s

pe

cia

lise

d m

uco

visc

ido

sis

cen

tre

wh

ere

a

swe

at

test

ta

ke

s p

lace

a

s co

nfi

rma

tio

n

exa

min

ati

on

. P

lea

se

con

sid

er

tha

t a

re

sult

wh

ich

ne

ed

s a

fo

llo

w u

p e

xam

ina

tio

n d

oe

s

no

t m

ea

n t

ha

t y

ou

r n

ew

bo

rn h

as

mu

covis

cid

osi

s. O

nly

on

e o

ut

of

five

ch

ild

ren

wit

h a

su

spic

iou

s re

sult

an

d w

ho

ne

ed

ed

a f

ollo

w

up

exa

min

ati

on

act

ua

lly h

as

mu

covis

cid

osi

s. F

urt

he

rmo

re,

the

swe

at

test

is

ha

rmle

ss a

nd

pa

inle

ss a

nd

do

es

no

t st

ress

yo

ur

ba

by.

Yo

u d

eci

de

fo

r y

ou

r b

ab

y!

Th

e

pa

rtic

ipa

tio

n

in

the

m

ass

scre

en

ing

is

volu

nta

ry.

Als

o t

he

cost

s fo

r th

is

exa

min

ati

on

a

re

take

n

if

you

a

re

insu

red

in

a

sta

tuto

ry h

ea

lth

in

sura

nce

. T

he

resu

lts

of

this

e

xam

ina

tio

n

un

de

rlie

th

e

me

dic

al

con

fid

en

tia

lity

an

d m

ay

no

t b

e

tra

nsm

itte

d

to

oth

er

pe

rso

ns

wit

ho

ut

you

r a

gre

em

en

t.

Th

e

scre

en

ing

la

bo

rato

ry

tra

nsm

its

the

re

sult

s d

ire

ctly

to

th

e

resp

on

sib

le p

ers

on

wh

o c

on

tact

s yo

u i

n c

ase

of

a p

osi

tiv

e r

esu

lt.

Yo

u h

ave

th

e r

igh

t to

re

vo

ke

yo

ur

ag

ree

me

nt

to p

art

icip

ate

in

the

mu

cov

isci

do

sis

ma

ss s

cre

en

ing

at

an

y t

ime

.

No

tice

:

Als

o a

n e

arl

y tr

ea

tme

nt

can

no

t p

reve

nt

con

seq

ue

nce

s o

f

the

me

nti

on

ed

dis

ea

ses

com

ple

tely

in

all

ca

ses.

Ho

we

ve

r,

an

im

me

dia

te

tre

atm

en

t m

ak

es

a

no

rma

l d

eve

lop

me

nt

po

ssib

le f

or

con

cern

ed

ch

ild

ren

in

th

e m

ost

ca

ses.

Imp

ort

an

t F

RA

ME

wo

rk c

on

dit

ion

s

Th

e p

art

icip

ati

on

in

th

e n

ew

bo

rn s

cre

en

ing

exa

min

ati

on

s is

vo

lun

tary

. Y

ou

r a

gre

em

en

t to

pa

rtic

ipa

te i

ncl

ud

es

a t

est

fo

r

the

he

re m

en

tio

ne

d d

ise

ase

s.

Da

ta p

rote

ctio

n:

Th

e f

ilte

r p

ap

er

card

an

d t

he

pa

rt w

ith

pe

rso

na

l d

ata

of

yo

u a

nd

yo

ur

ba

by a

re s

ep

ara

ted

aft

er

the

an

aly

ses

ha

ve

b

ee

n

fin

ish

ed

. T

he

e

xam

ine

d

dri

ed

b

loo

d

sam

ple

is

de

stro

ye

d a

fte

r fi

nis

hin

g o

f a

ll a

na

lyse

s (a

t th

e

late

st a

fte

r 3

mo

nth

s).

Th

e

resu

lts

of

the

e

xam

ina

tio

ns

un

de

rlie

th

e

me

dic

al

con

fid

en

tia

lity

a

nd

m

ay

no

t b

e

tra

nsm

itte

d

to

oth

er

pe

rso

ns

wit

ho

ut

yo

ur

ag

ree

me

nt.

Th

e co

sts

for

this

e

xam

ina

tio

n a

re

ov

ert

ake

n

if y

ou

a

re

insu

red

in

a s

tatu

tory

he

alt

h i

nsu

ran

ce.

If y

ou

are

pri

va

tely

insu

red

th

e c

ost

s a

re n

orm

all

y a

lso

ov

ert

ake

n,

ho

we

ve

r, f

or

furt

he

r d

eta

ils

ple

ase

co

nta

ct y

ou

r in

sura

nce

co

mp

an

y.

In

ca

se y

ou

ha

ve

an

y f

urt

he

r q

ue

stio

ns

ab

ou

t th

e t

op

ic o

f th

e

ne

wb

orn

scr

ee

nin

g,

ple

ase

co

nta

ct y

ou

r m

ate

rny c

lin

ic o

r yo

ur

pa

ed

iatr

ist.

Ou

r te

am

of

the

ne

wb

orn

scr

ee

nin

g l

ab

ora

tory

wis

he

s y

ou

an

d y

ou

r b

ab

y a

ll t

he

be

st f

or

yo

ur

futu

re.

Un

ive

rsit

äts

kli

nik

um

Ma

gd

eb

urg

A .

ö.R

.

Ott

o-v

on

-Gu

eri

cke

-Un

ive

rsit

ät

Inst

itu

t fü

r K

lin

isch

e C

he

mie

un

d

Pa

tho

bio

che

mie

Lab

or

für

Ne

ug

eb

ore

ne

nsc

ree

nin

g

Leip

zig

er

Str

e 4

4 /

Ha

us

39

39

12

0 M

ag

de

bu

rg -

Ge

rma

ny

Te

lep

ho

ne

: +

49

39

1 6

7-1

39

59

Te

lefa

x:

+4

9 3

91

67

-29

03

61

ng

-scr

ee

nin

g@

me

d.o

vg

u.d

e

ww

w.s

twz.

ovg

u.d

e

ww

w.m

ed.u

ni-

mag

debu

rg.d

e

Fly

er

Da

te:

01

/20

17

Wh

ich

dis

ea

ses

are

in

clu

de

d i

n t

he

ne

wb

orn

scre

en

ing

?

Co

ng

en

ita

l a

dre

na

l

hy

pe

rpla

sia

E

nd

ocr

ine

d

iso

rde

r d

ue

to

d

efe

ct

of

the

a

dre

na

l co

rte

x:

an

dro

ge

nis

ati

on

at

gir

ls,

po

ssib

le

leth

al

ou

tco

me

a

t

salt

w

ast

ing

cr

isis

. T

rea

tme

nt

by

ho

rmo

ne

in

tak

e.

(Fre

qu

en

cy:

ap

pro

x.

1/1

0,0

00

ne

wb

orn

s)

Ma

ple

sy

rup

uri

ne

dis

ea

se

De

gra

da

tio

n

de

fect

o

f a

min

o

aci

ds:

me

nta

lly

ha

nd

ica

pp

ed

, co

ma

, p

oss

ible

leth

al

ou

tco

me

. T

rea

tme

nt

by

sp

eci

al

die

t.

(Fre

qu

en

cy:

ap

pro

x.

1/2

00

,00

0

ne

wb

orn

s)

Bio

tin

ida

se d

efi

cie

ncy

M

eta

bo

lic

de

fect

o

f th

e

vit

am

in

bio

tin

: S

kin

a

lte

rati

on

, m

eta

bo

lic

cris

is,

me

nta

lly

h

an

dic

ap

pe

d.

Tre

atm

en

t b

y

bio

tin

in

tak

e.

(Fre

qu

en

cy:

1/8

0,0

00

ne

wb

orn

s)

Ca

rnit

ine

me

tab

oli

c d

iso

rde

r M

eta

bo

lic

dis

ord

er

of

fatt

y

aci

ds:

me

tab

oli

c cr

isis

, co

ma

, p

oss

ible

le

tha

l

ou

tco

me

. T

rea

tme

nt

by

sp

eci

al

die

t.

(Fre

qu

en

cy:

ap

pro

x.

1/1

00

,00

0

ne

wb

orn

s)

Ga

lact

ose

mia

Im

pa

ire

d

me

tab

oli

sm

of

lact

ose

sug

ars

: B

lin

dn

ess

, p

hy

sica

l a

nd

inte

lle

ctu

al

dis

ab

ilit

y,

live

r fa

ilu

re,

po

ssib

ly r

esu

ltin

g i

n d

ea

th.

Tre

atm

en

t

thro

ug

h a

sp

eci

al

die

t

(Fre

qu

en

cy:

ap

pro

x.

1/4

0,0

00

ne

wb

orn

s).

Glu

tari

c a

cid

em

ia t

yp

e 1

D

eg

rad

ati

on

d

efe

ct

of

am

ino

a

cid

s:

pe

rma

ne

nt

mo

ve

me

nt

dis

ord

er,

sud

de

n m

eta

bo

lic

cris

is.

Tre

atm

en

t b

y

spe

cia

l d

iet.

(F

req

ue

ncy

: a

pp

rox.

1/8

0,0

00

ne

wb

orn

s)

Hy

po

thy

reo

sis

Co

ng

en

ita

l h

yp

oth

yro

sis:

S

eve

re

me

nta

lly

a

nd

p

hy

sica

l d

eve

lop

me

nt

dis

ord

er.

Tre

atm

en

t b

y h

orm

on

e i

nta

ke

.

(Fre

qu

en

cy:

ap

pro

x. 1

/4,0

00

ne

wb

orn

s)

Iso

va

leri

c a

cid

ae

mia

: D

eg

rada

tio

n defe

ct

of

am

ino acid

s:

me

nta

lly

ha

nd

ica

pp

ed

, com

a.

Tre

atm

en

t b

y s

pe

cia

l die

t an

d i

nta

ke

of

am

ino a

cid

s.

(Fre

qu

en

cy:

app

rox.

1/5

0,0

00 n

ew

born

s)

LCH

AD

/VLC

AD

M

eta

bolic

defe

ct

of

long-c

hain

fa

tty

acid

s:

meta

bolic

crisis

, com

a,

mya

sth

enia

, m

yocard

ial in

suff

icie

ncy,

po

ssib

le

leth

al

outc

om

e.

Tre

atm

ent

by

spe

cia

l d

iet,

pre

ve

ntion

of

sta

rva

tio

n

peri

od

s.

(Fre

qu

en

cy:

ap

pro

x. 1

/80

,000

ne

wbo

rns)

MC

AD

-de

fici

en

cy

En

erg

y

pro

du

ctio

n

de

fect

fr

om

fa

tty

aci

ds:

m

eta

bo

lic

cris

is,

com

a,

po

ssib

le

leth

al

ou

tco

me

. T

rea

tme

nt

by

in

tak

e o

f

carn

itin

e,

pre

ven

tio

n

of

sta

rva

tio

n

pe

rio

ds.

(F

req

ue

ncy

: a

pp

rox.

1

/10

,00

0

ne

wb

orn

s)

Ph

en

ylk

eto

nu

ria

M

eta

bo

lic

de

fect

o

f th

e

am

ino

a

cid

ph

en

yla

lan

in:

seiz

ure

s,

spa

stic

ity

,

me

nta

lly

h

an

dic

ap

pe

d.

Tre

atm

en

t b

y

spe

cia

l d

iet.

(F

req

ue

ncy

: a

pp

rox.

1/1

0,0

00

ne

wb

orn

s)

Mu

cov

isci

do

sis

(sin

ce 0

9/2

01

6)

Als

o

call

ed

cy

stic

fi

bro

sis.

D

efe

ct

of

a

tra

nsp

ort

pro

tein

(C

FT

R).

Ca

use

s a

sa

lt

exc

ha

ng

e

dis

ord

er

in

the

g

lan

d

cell

s.

Vis

cou

s m

uco

us

form

ati

on

in

th

e

resp

ira

tory

tr

act

a

nd

o

rga

ns

wh

ich

be

com

e

pe

rma

ne

ntl

y

infl

am

ed

. R

eli

ef

an

d

imp

rov

em

en

t o

f sy

mp

tom

s b

y

foll

ow

ing

tr

ea

tme

nt:

in

ha

lati

on

,

ph

ysi

oth

era

py

, sp

eci

al

die

t,

dru

gs.

(Fre

qu

en

cy:

1/3

,30

0 n

ew

bo

rns)

Ne

wb

orn

he

ari

ng

scr

ee

nin

g

He

ari

ng

d

iso

rde

rs a

re

the

m

ost

fr

eq

ue

nt

sen

sory

d

iso

rde

rs

du

rin

g

infa

ncy

w

ith

mu

ltip

le r

ea

son

s, p

art

ly a

pp

ea

rin

g i

n c

om

bin

ati

on

wit

h o

the

r d

ise

ase

s (c

ard

iac-

,

ren

al-

an

d v

isu

al

dis

ord

ers

). E

arl

y d

ete

ctio

n a

nd

th

era

py

sta

rtin

g a

re c

on

dit

ion

fo

r

an

o

pti

ma

l li

ng

uis

tic

an

d

me

nta

l d

ev

elo

pm

en

t.

To

o

late

d

ete

ctio

n

cau

ses

pe

rma

ne

nt

da

ma

ge

s. T

he

rap

y:

am

on

g o

the

rs s

up

po

rt,

he

ari

ng

de

vic

e s

up

ply

an

d i

f

ne

cess

ary

co

chle

a i

mp

lan

t. (

Fre

qu

en

cy a

pp

rox.

1-3

/10

00

ne

wb

orn

s)

NE

WB

OR

N S

CR

EE

NIN

G

Info

rma

tio

n f

or

pa

ren

ts

For

ea

rly

de

tect

ion

of

con

ge

nit

al

dis

ord

ers

at

ne

wb

orn

s.

Incl

usi

ve

- S

cre

en

ing

fo

r m

uco

vis

cid

osi

s

Page 2: CREENING Information for parents For early detection of ... · Newborn hearing screening Hearing disorders are the most frequent sensory dis orders during infancy with multiple reasons,

De

ar

pa

ren

ts,

yo

u e

xpe

ct yo

ur

ba

by t

o b

e b

orn

soo

n

or

it

just

cam

e

into

th

e

wo

rld

. Y

ou

de

ep

ly w

ish

th

at

it

wil

l g

row

u

p

he

alt

hy.

Fo

r th

is

rea

son

o

ur

ha

nd

ou

t in

form

s

you

a

bo

ut

the

e

arl

y d

ete

ctio

n

exa

min

ati

on

s o

f th

e

Ne

wb

orn

Scr

ee

nin

g,

wh

ich

ta

ke

s p

lace

on

ly a

fe

w d

ays

aft

er

bir

th o

f yo

ur

ba

by.

Wh

y d

o w

e c

arr

y o

ut

ea

rly

de

tect

ion

exa

min

ati

on

s?

Mo

st c

hil

dre

n a

re b

orn

he

alt

hy a

nd

als

o s

tay

he

alt

hy

du

rin

g t

he

ir

life

. H

ow

eve

r, s

om

e n

ew

bo

rns

are

aff

ect

ed

by

rare

ly a

pp

ea

rin

g

con

ge

nit

al

dis

ea

ses

wh

ich

a

re

no

t d

ete

cta

ble

b

y o

ute

r si

gn

s.

Ap

pro

xim

ate

ly,

on

e o

ut

of

10

00

ne

wb

orn

s su

ffe

rs f

rom

su

ch a

rare

ly a

pp

ea

rin

g c

on

ge

nit

al

dis

ord

er

of

the

me

tab

oli

sm o

r o

f th

e

org

an

fu

nct

ion

a

nd

it

s h

ea

lth

is

th

ere

by

in

da

ng

er.

A

n

ea

rly

tre

atm

en

t a

fte

r b

irth

ca

n

avo

id

con

seq

ue

nce

s o

f co

ng

en

ita

l

dis

ea

ses

in

the

m

ost

ca

ses.

T

he

refo

re,

ev

ery

n

ew

bo

rn

in

Ge

rma

ny

is

exa

min

ed

a

lre

ad

y

for

mo

re

tha

n

30

ye

ars

. T

he

me

tab

olic

test

s a

re

imp

rov

ed

st

ea

dil

y

an

d

furt

he

r tr

ea

tab

le

dis

ea

ses

ha

ve

be

en

in

clu

de

d i

nto

th

e e

xam

ina

tio

ns.

Wh

en

pa

rtic

ipa

tin

g i

n t

his

in

ve

stig

ati

on

pro

gra

m y

ou

he

lp t

o

en

sure

th

e h

ea

lth

ine

ss o

f y

ou

r b

ab

y.

If y

ou

are

in

sure

d u

nd

er

a

sta

tuto

ry i

nsu

ran

ce p

lan

, n

o f

urt

he

r co

sts

ari

se.

Wh

en

an

d h

ow

do

we

ca

rry

ou

t

the

exa

min

ati

on

s?

Th

e s

cre

en

ing

exa

min

ati

on

s ta

ke

pla

ce d

uri

ng

th

e s

eco

nd

or

thir

d

da

y o

f li

fe

(36

th

- 7

2n

d

ho

ur

aft

er

bir

th),

w

he

re

ap

pro

pri

ate

als

o i

n c

on

ne

ctio

n w

ith

th

e s

eco

nd

ea

rly

de

tect

ion

exa

min

ati

on

o

f th

e

ne

wb

orn

(s

o-c

all

ed

U

2).

A

fe

w

dro

ps

of

blo

od

are

ta

ke

n f

rom

ve

in o

r h

ee

l o

f th

e n

ew

bo

rn a

nd

dro

pp

ed

on

th

e c

orr

esp

on

din

g f

ilte

r p

ap

er

card

wit

h t

he

pu

rpo

se t

o b

e

sen

d

imm

ed

iate

ly

aft

er

dry

ing

to

th

e

scre

en

ing

la

bo

rato

ry.

Th

ere

, th

e

sam

ple

s a

re

exa

min

ed

in

sta

ntl

y

by

ve

ry

spe

cia

l,

sen

siti

ve

me

tho

ds.

Wh

ich

dis

ea

ses

can

be

de

tect

ed

by

ou

r N

ew

bo

rn S

cre

en

ing

?

Co

ng

en

ita

l h

yp

oth

yre

osi

s, c

on

ge

nit

al

ad

ren

al

hy

po

pla

sia

(C

AH

),

bio

tin

ida

se

de

fici

en

cy,

ga

lact

ose

mia

, p

he

ny

lke

ton

uri

a

(PK

U)/

hyp

erp

he

nyla

lan

ine

mia

(H

PA

),

ma

ple

sy

rup

u

rin

e

dis

ea

se

(MS

UD

), f

att

y a

cid

me

tab

oli

sm d

efe

cts

(MC

AD

-, L

CH

AD

-, V

LCA

D

de

fici

en

cy),

ca

rnit

ine

cycl

e d

efi

cie

nci

es,

glu

tari

c a

cid

uri

a t

yp

e I

an

d i

sov

ale

ric

aci

da

em

ia (

IVA

) (d

ise

ase

s e

xact

ly d

esc

rib

ed

in

th

e

foll

ow

ing

). A

te

st f

or

mu

covi

scid

osi

s (c

yst

ic f

ibro

sis)

fo

rms

pa

rt

of

the

scr

ee

nin

g s

ince

20

16

. In

mo

st o

f th

e c

on

cern

ed

fa

mil

ies

such

dis

ea

ses

did

no

t a

pp

ea

r b

efo

re.

Th

e n

ew

bo

rn s

cre

en

ing

is

of

gre

at

imp

ort

an

ce b

eca

use

co

nce

rne

d n

ew

bo

rns

oft

en

se

em

to

be

e c

om

ple

tely

he

alt

hy a

t b

irth

. W

e w

an

t to

pro

tect

th

em

fro

m

sev

ere

dis

ea

ses

an

d t

he

ir c

on

seq

ue

nce

s su

ch a

s se

ve

re d

iso

rde

rs

in m

en

tal

an

d p

hysi

cal

de

ve

lop

me

nt.

So

me

of

the

me

nti

on

ed

dis

ea

ses

are

in

he

rite

d.

Fo

r th

is r

ea

son

th

e n

ew

bo

rn s

cre

en

ing

exa

min

es

ge

ne

tic

tra

its

an

d i

s th

ere

fore

of

cou

rse

su

bje

cte

d t

o

the

re

gu

lati

on

s o

f th

e G

en

e D

iag

no

stic

s A

ct.

Wh

at

do

es

the

te

stin

g r

esu

lt t

ell

us?

T

he

re

sult

o

f a

sc

ree

nin

g

test

is

n

o

me

dic

al

dia

gn

osi

s a

nd

a

req

ue

st

for

a

follo

w

up

e

xam

ina

tio

n

do

es

no

t a

uto

ma

tica

lly

me

an

th

at

yo

ur

ba

by

is

ill.

By m

ea

ns

of

the

te

stin

g r

esu

lt i

t is

po

ssib

le r

ath

er

to e

xclu

de

th

e c

on

cern

ed

in

vest

iga

ted

dis

ord

ers

or

to r

eq

uir

e a

no

the

r d

iag

no

stic

exa

min

ati

on

up

on

su

spic

ion

of

a

dis

ea

se.

Ho

we

ve

r, a

re

pe

titi

on

of

a t

est

ca

n a

lso

be

ne

cess

ary

in

case

th

e p

oin

t o

f ti

me

of

blo

od

ta

kin

g w

as

no

t o

pti

ma

l o

r th

e

am

ou

nt

of

blo

od

wa

s n

ot

suff

icie

nt

for

all

te

sts.

We

kin

dly

ask

yo

u

to

rea

ct

qu

ickl

y

wh

en

yo

u

are

a

ske

d

to

pa

rtic

ipa

te

in

a

foll

ow

up

exa

min

ati

on

. It

is

in t

he

in

tere

st o

f yo

ur

ba

by

wh

en

th

e

situ

ati

on

is

cla

rifi

ed

ra

pid

ly.

Is it

po

ssib

le t

o c

ure

th

ese

dis

ea

ses?

All

m

en

tio

ne

d

me

tab

oli

c d

efe

cts

an

d e

nd

ocr

ine

d

iso

rde

rs

are

con

ge

nit

al

an

d c

an

no

t b

e c

ure

d.

Ho

we

ve

r, t

he

co

nse

qu

en

ces

of

the

se c

on

ge

nit

al

dis

ord

ers

ca

n b

e p

rev

en

ted

or

at

lea

st r

ed

uce

d

by a

n e

arl

y t

rea

tme

nt.

Tre

atm

en

t d

oe

s m

ea

n e

ith

er

a s

pe

cia

l

die

t a

nd

or

the

in

tak

e o

f ce

rta

in d

rug

s. I

n c

ase

of

mu

covis

cid

osi

s

the

re a

re n

ew

, im

pro

ve

d t

he

rap

eu

tic

ap

pro

ach

es,

so

th

at

the

lif

e

exp

ect

an

cy o

f co

nce

rne

d p

ati

en

ts h

as

incr

ea

sed

co

nti

nu

ou

sly.

Sp

eci

ali

sts

for

me

tab

oli

sm,

ho

rmo

ne

s a

nd

mu

cov

isci

do

sis

are

at

yo

ur

dis

po

sal

for

con

sult

ati

on

an

d s

up

po

rt i

n c

ase

of

susp

icio

n o

f

a d

ise

ase

or

illn

ess

.

Wh

o

is

info

rme

d

ab

ou

t th

e

test

ing

re

sult

?

In e

ve

ry c

ase

th

e s

en

de

r o

f th

e b

loo

d s

am

ple

(m

ate

rny c

lin

ic,

pa

ed

iatr

ist)

re

ceiv

es

wit

hin

a f

ew

da

ys

a w

ritt

en

fin

din

g a

bo

ut

the

re

sult

o

f th

e

ho

rmo

ne

, m

eta

bo

lism

a

nd

m

uco

vis

cid

osi

s

scre

en

ing

. T

he

re

sult

un

de

rlie

s th

e m

ed

ica

l co

nfi

de

nti

ali

ty a

nd

ma

y n

ot

be

tr

an

smit

ted

to

a

ny

oth

er

pe

rso

n

wit

ho

ut

yo

ur

de

cla

rati

on

of

con

sen

t. Y

ou

as

pa

ren

ts d

o n

orm

all

y n

ot

rece

ive

the

fin

din

g.

In u

rge

nt

case

s yo

u w

ill

be

co

nta

cte

d i

mm

ed

iate

ly.

Th

ere

fore

, w

e k

ind

ly a

sk y

ou

to

in

dic

ate

yo

ur

tele

ph

on

e n

um

be

r

an

d a

dd

ress

on

th

e t

est

ing

ca

rd,

wh

ere

yo

u c

an

be

co

nta

cte

d

du

rin

g t

he

fir

st d

ays

aft

er

bir

th o

f yo

ur

ba

by.

Th

e f

oll

ow

ing

ap

pli

es

for

yo

u:

No

Ne

ws

are

Go

od

Ne

ws

E

arl

y d

ete

ctio

n a

nd

tre

atm

en

t o

f co

nce

rne

d n

ew

bo

rns

is o

nly

po

ssib

le

wh

en

a

ll

pa

rtie

s su

ch

as

pa

ren

ts,

ma

tern

y cl

inic

,

pa

ed

iatr

ist

an

d

scre

en

ing

la

bo

rato

ry

wo

rk

tog

eth

er

wit

ho

ut

wa

stin

g

of

tim

e

in

ord

er

to

fin

ish

th

e

test

ing

re

sult

s

imm

ed

iate

ly a

nd

te

sts

can

b

e

rep

ea

ted

if

ne

cess

ary

. Y

ou

a

re

on

ly

info

rme

d

ab

ou

t

un

susp

icio

us

test

ing

resu

lts

up

on

p

ers

on

al

req

ue

st

at

yo

ur

ma

tern

y

clin

ic

or

pa

ed

istr

ist.

Scr

ee

nin

g f

or

mu

covi

scid

osi

s A

t th

e s

am

e t

ime

wit

h a

n e

nla

rge

d n

ew

bo

rn s

cre

en

ing

yo

u a

re

off

ere

d a

ma

ss s

cre

en

ing

fo

r m

uco

vis

cid

osi

s a

fte

r b

irth

of

yo

ur

ba

by.

Aim

o

f th

is

scre

en

ing

is

a

n

ea

rly

d

ete

ctio

n

of

mu

covi

scid

osi

s so

th

at

a t

he

rap

y ca

n s

tart

as

soo

n a

s p

oss

ible

an

d

the

q

ua

lity

o

f li

fe

an

d

life

e

xpe

cta

ncy

o

f ch

ild

ren

w

ith

mu

covi

scid

osi

s ca

n b

e i

mp

rov

ed

.

Wh

at

is m

uco

vis

cid

osi

s?

Mu

covis

cid

osi

s (a

lso

ca

lle

d c

yst

ic f

ibro

sis)

is

a c

on

ge

nit

al

dis

ea

se

wh

ich

a

pp

ea

rs

ap

pro

xim

ate

ly

at

on

e

ou

t o

f 3

30

0

ne

wb

orn

s.

He

re,

a g

en

e a

lte

rati

on

of

the

so

ca

lle

d C

FT

R g

en

e c

au

ses

a s

alt

exc

ha

ng

e

dis

ord

er

in

the

g

lan

d

cell

s.

Th

is

cau

ses

the

de

ve

lop

me

nt

of

vis

cou

s m

ucu

s in

th

e r

esp

ira

tory

tra

ct a

nd

oth

er

org

an

s w

hic

h

the

refo

re

be

com

e

chro

nic

all

y

infl

am

ed

. T

he

sev

eri

ty o

f sy

mp

tom

s ca

n v

ary

du

e t

o d

iffe

ren

t g

en

e a

lte

rati

on

s.

Als

o

the

p

an

cre

ati

c fu

nct

ion

is

li

mit

ed

. T

he

refo

re

con

cern

ed

chil

dre

n a

re o

fte

n u

nd

erw

eig

ht

an

d d

o n

ot

gro

w v

ery

go

od

. In

sev

ere

ca

ses

an

d

in

case

o

f fr

eq

ue

ntl

y

ap

pe

ari

ng

lu

ng

infl

am

ma

tio

ns

the

p

ulm

on

ary

fu

nct

ion

ca

n

be

si

gn

ific

an

tly

imp

air

ed

.

Wh

y d

oe

s a

ma

ss s

cre

en

ing

fo

r m

uco

vis

cid

osi

s

ma

ke

s se

nse

?

A m

ass

scr

ee

nin

g f

or

mu

covis

cid

osi

s e

na

ble

s a

n e

arl

y d

iag

no

sis.

An

d

an

e

arl

y

the

rap

y

sta

rtin

g

can

im

pro

ve

th

e

ph

ysi

cal

de

ve

lop

me

nt

of

con

cern

ed

ch

ild

ren

. T

he

reb

y t

he

ch

an

ce o

f a

lon

ge

r a

nd

mo

re h

ea

lth

y lif

e i

ncr

ea

ses.

Ho

w c

an

mu

cov

isci

do

sis

be

tre

ate

d?

A

t th

e m

om

en

t th

ere

is

no

he

ali

ng

th

era

py

for

mu

covi

scid

osi

s.

Ho

we

ve

r,

the

sy

mp

tom

s ca

n

be

im

pro

ve

d

or

reli

ev

ed

b

y

dif

fere

nt

the

rap

ies,

so

th

at

the

li

fe

exp

ect

an

cy

ha

s in

cre

ase

d

con

tin

uo

usl

y

du

rin

g

the

la

st

de

cad

es.

T

he

tr

ea

tme

nt

of

mu

covi

scid

osi

s co

nsi

sts

in i

nh

ala

tio

ns

an

d p

hy

sio

the

rap

y,

a d

iet

wh

ich

is

e

xtre

me

ly

rich

in

ca

lori

es

an

d

the

in

tak

e

of

dru

gs.

Fu

rth

erm

ore

, it

is

u

sefu

l to

a

tte

nd

co

nst

an

tly

ce

rta

in

con

tro

l

exa

min

ati

on

s in

sp

eci

ali

sed

mu

covi

scid

osi

s ce

ntr

es

to d

ete

ct a

nd

tre

at

ea

rly

cha

ng

es

of

the

dis

ea

se.